Several point mutations within the PDZ domain of the HTRA2 gene have been identified in patients with Parkinson’s disease, and these mutations are demonstrated to result in HtrA2 inactivation and mitochondrial dysfunction in vitro [76]. The gene discussed is HTRA2; the disease is Parkinson disease.